Abstract
Objective
This study was conducted to characterize the antioxidant and anti-inflammatory properties of Rubber Seed Oil (RSO) against atherosclerosis (AS) through the study of the protective effects and mechanisms on human umbilical vein endothelial cells (HUVECs) injury induced by oxidized low-density lipoprotein (ox-LDL).
Methods
HUVECs were treated with RSO, ox-LDL, RSO + ox-LDL, respectively, followed by cell activity testing, levels of IL-1β, IL-6, IL-10, TNF-α, ROS, NO, the mRNA expression of eNOS and protein expression of MCP-1, VCAM-1, eNOS, TLR4, NF-κB p65、p-NF-κB p65.
Results
Compared with the ox-LDL group, cell viability, NO level and the expression of eNOS mRNA significantly increased. and the levels of pro-inflammatory factors such as IL-1β, IL-6, TNF-α, IL-10, ROS were significantly decreased, which was accompanied by decreases in TLR4 mRNA, TLR4, MCP-1, VCAM-1 protein expression, as well as the ratio of NF-κB p-p65/p65 in the group treated with 250 μg/ml ox-LDL + 50 μg/ml RSO, 250 μg/ml ox-LDL + 100 μg/ml RSO, 250 μg/ml ox-LDL + 150 μg/ml RSO.
Conclusions
RSO can reduce the expression of pro-inflammatory mediators, oxidative factors involved in injured vascular endothelial cells, exhibiting anti-inflammatory and antioxidant properties HUVECs exposed to ox-LDL. In addition, it may alleviate endothelial cell damage by inhibiting the TLR4/NF-κB signaling pathway.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
As the leading cause of mortality in developed countries, atherosclerosis (AS) is a systemic multifactorial disease characterized by lipid deposition, inflammatory factors aggregation, and vascular smooth muscle cells (VSMCs) proliferation accompanied by fibrous matrix hyperplasia (Grootaert and Bennett 2021). The accumulation of oxidized low density lipoprotein (ox-LDL) is an important event in the pathogenesis of atherosclerosis (Kattoor et al. 2019). When endothelial cells are damaged or subjected to metabolic stress conditions, it will lead to an increase in reactive oxygen species (ROS) production (Chatzizisis et al. 2007). Correspondingly, increased level of ROS can result in the production of ox-LDL (Förstermann and Sessa 2012). ox-LDL causes the increase of leukocyte adhesion molecules in endothelial cells, activates the apoptosis pathway, and leads to endothelial dysfunction, plaque instability and thrombosis (Kattoor et al. 2019). Hence, it may lead to the occurrence of acute cardiovascular disease (Miano et al. 2021). In recent years, the roles of inflammation and oxidative stress in atherosclerosis had attracted increased attention (Zhu et al. 2018; Poznyak et al. 2021; Kattoor et al. 2017).
Rubber seeds are one of the main by-products of natural rubber plantations, which are very rich in oil, called rubber seed oil (RSO), with 40–50% oil content of the seed kernel (Azócar et al. 2010). In recent years, some preliminary studies have concluded that RSO has no toxicity (Gandhi et al. 1990) and possesses increased catalase activities in fish (Deng et al. 2015) and radical scavenging abilities as a cosmetic (Lourith et al. 2014). In several studies, RSO exhibited anti-inflammatory property because it can reduce the level of proinflammatory factors (TNF-α and INF-γ) in fish and inhibit the production of NO, IL-1β, IL-6 in lipopolysaccharide-induced RAW 267.4 macrophages (Pi et al. 2019; Liu et al. 2022). However, the roles of RSO in human diseases are not well understood.
In this study, we expose human umbilical vein endothelial cells (HUVECs) to ox-LDL to simulate the development of AS pathology to study the effects of RSO on inflammatory and oxidative factor levels. Further, relevant signaling transduction pathways are studies to elucidate the mechanism of anti-AS effects. Our aim is to provide a theoretical basis for the further application of RSO in the treatment of human diseases.
Methods
Cell culture
The HUVECs cells (BeNa Culture Collection, Suzhou, China) were cultured in specialized culture medium (Procell Life Technology Co., Ltd, Wuhan, China) in a humidified atmosphere at 37℃ containing 5% CO2 and were sub-cultured every two to three days to maintain an exponential growth phase during experiments.
Preparation for RSO
The RSO used in this study was provided by Huakun Biotechnology Co., Ltd. In Xishuangbanna, Yunnan, China. The seed oil was made from Brazilian rubber tree seeds and processed through raw material cleaning, drying, shelling, pressing, and refining. RSO was sterilized by filtration though a 0.2 µm membrane (Jiete Biofiltration Co., Ltd, Guangzhou, China) and dissolved in acetone (Wansheng Chuandong Chemical Co., Ltd, Chongqing).
Cell viability testing
In the cell viability testing, cells were inoculated into the 96-well plate (Beyotime Biotechnology, Shanghai, China with a density of 1 × 105 cells/well and cultured for 3 h until the cells adhered to the plate Then, the cells were treated with RSO in different concentration (25, 50, 75, 100, 125, 150, 200 µg/mL), as the previous study described (Liu et al. 2022), and ox-LDL (Solaybao Technology Co., Ltd, Beijing, China) at 12.5, 25, 50, 100, 150, 200, 250, 300 µg/mL, respectively, for 24 h.
After 24 h treatment, the original culture medium from the 96 well plate was extracted and 10μL CCK-8 reagent (Proteintech, Chicago, USA) was added to each well. After 1 h incubation, Optical Density (OD) was measured at 450 nm in the culture plate using a plate reader (BioTek, Vermont, USA).
Determination of inflammatory cytokines
Supernatant from each treatment group described above was collected and stored at -20℃ until analyses. Levels of IL-1β, IL-6, IL-10, GSH and TNF-α were determined by an ELISA kit (Huamei Bioengineering Co., Ltd, Wuhan China) at 450 nm in triplicates (Kaval et al. 2022; Chen et al. 2021). Concentrations of inflammatory cytokines were calculated by standard curves and expressed as microgram or nanogram per milliliter per manufacturer’s instructions.
Detection of intracellular ROS levels
The levels of intracellular ROS were analyzed using a ROS Assay Kit (Fu et al. 2023), a fluorescence enzyme-linked immunosorbent assay (Solaybao Technology Co., Ltd, Beijing, China). The DCFH-DA was diluted to 10 µmol/L and added to each well so that it can cover all cells. Next, the cells were incubated at 37℃ for 20 min. After discarding the culture medium, serum-free culture medium was used to wash the cells three times with gentle shaking. ROS levels were detected and plate reader, with parameter settings of 488 nm excitation wavelength and 525 nm emission wavelength (BioTek, Vermont, USA).
Determination of NO
NO levels were measured with a NO detection kit, an enzyme-linked immunosorbent assay (Beyotime Biotechnology Co., Ltd, Shanghai, China). 60 μl of cell supernatant was added to each well in a 96 well plate with 5 μl NADPH, FAD, and Nitrate Reductase reagents incubated at 37 º C for 30 min. Then, the cells were incubated with LDH Buffer and LDH at 37 ℃ for 30 min. Next, 50 µl Griess reagent I and 50 µl Griess reagent II were added to each well at room temperature (20–30 ℃) for 10 min, and the OD value at 540 nm was measured with a plate reader (BioTek, Vermont, USA).
RNA extraction and PCR
Cells were washed with PBS for three times after treatment. Total RNA was extracted from cells with Trizol (Solaybao Technology Co., Ltd, Beijing, China) and chloroform (Shandian Pharmaceutical Co., Ltd, Yunnan, China). The total RNA was collected in the aqueous phase after centrifugation ands precipitated by isopropanol (Jingrui Technology Co., Ltd, Yunnan, China). The pellet was washed with 75% ethanol, and redissolved in RNAase-free water. The concentration and purity of the total RNA were determined using a spectrophotometer. Quantitive RT-PCR (Sangon Biotech, Shanghai, China) was used measure the expression levels of genes are below (Table 1) in triplicate assays. Based on the threshold cycle (Ct) values of the target genes and internal control gene, the relative expression level of target genes in each group was calculated by the 2−ΔΔct method.
Western blot
After the cells were washed twice with PBS, 200 µl of lysing buffer was added to each well, and placed it on ice for 30 min; 4 ℃, 12,000 rpm, centrifugation for 30 min; Then the protein concentration was detected using the BCA kit (Biyuntian Biotechnology Co., Ltd, Shanghai, China), followed by heating in a metal bath at 95 ℃ for 15 min and cooling at room temperature for denaturation.
SDS-PAGE separated the total protein, and the protein was transferred to the polyvinylidene fluoride (PVDF) membrane (Millipore, Massachusetts, USA). The PVDF membrane was sealed at room temperature for 1 h on a shaking table using a sealing solution prepared with TBST and skimmed milk powder (Wandashan Dairy Industry Co., Ltd, Hulin China). Then washed it with TBST three times, and immersed it in the prepared primary antibodies at 4 ℃ overnight. Then, washed it with TBST three times. Next, put the membrane into the secondary antibodies, which were incubating for 1 h. Finally, protein imprinting on the PVDF film can be displayed with a visualizer. Meanwhile, data was analyzed by Image J.
Antibodies: eNOS (1:2000, ABclonal, Wuhan, China), NF-κB p65 (1:1000, ABclonal, Wuhan, China), MCP-1 (1:2000, Proteintech, Chicago, USA), TLR4 (1:1000, Proteintech, Chicago, USA), VCAM-1 (1:2000, Hua'an Biotechnology Co., Ltd, Hangzhou, China), p-NF-κB p65 (1:500, Affinity Biosciences, Cincinnati, USA).
Statistical analysis
All experimental data were statistically analyzed using GraphPad Prism. Comparison between groups were conducted using conventional one-way ANOVA and the t-test. The statistical results were expressed as mean ± standard deviation (χ ± s), and P < 0.05 was considered statistically significant.
Results
RSO dissolves in acetone
In order to improve the effectiveness of RSO on cells, several solvents were screened for tehri ability to dissolve RSO. The results showed that RSO was insoluble in both DMSO (Dimethyl sulfoxide) and alcohol, the more commonly used solvent in cellular studies but soluble in acetone as previously reported (Agency for Toxic Substances and Disease Registry (ATSDR) 2022).
Effects of acetone on HUVECs
To determine effects of acetone as solvent on HUVECs, preliminary experiments were performed. HUVECs were treated with 0.01%, 0.1%, 1%, and 10% acetone (Wansheng Chuandong Chemical Co., Ltd, Linhai, China) and cell viability was assessed after 24 h treatment. It was found that acetone with concentration of less than 0.1% (v:v) had no significant effect on the cell viability of HUVECs (Fig. 1). Therefore, 0.1% acetone was selected to dissolve RSO in experiments reported here.
The effects of RSO and ox-LDL on the viability of HUVECs
To investigate the effects of RSO on HUVECs and reduce errors caused by operations or measurements, 0, 25, 50, 75, 100, 125, 150 μg/ml of RSO in 0.1% acetone were used to treat these cells in triplicates and CCK-8 kit was used to assess cell viability. The results demonstrated that there was no significant difference in cell viability between these groups (P > 0.05), indicating that RSO has no cytotoxicity on HUVECs (Fig. 2a). However, we need to choose RSO concentrations that have little influence on HUVECs cell viability, but there should be a certain difference to avoid similar results in different groups for subsequent experiments. Therefore, we chose the RSO at a concentration of 50, 100, and 150 μg/ml.
HUVECs were co-cultivated with ox-LDL in different concentrations (0, 12.5, 25, 50, 100, 150, 200, 250, 300 μg/ml) for 24 h to determine the appropriate concentration of ox-LDL for simulating the damage process of endothelial cells during arteriosclerosis in the human body. And 100 μg/ml, 150 μg/ml, 200 μg/ml, 250 μg/ml, 300 μg/ml ox-LDL can significantly decrease the cell viability of HUVECs (P < 0.01) in a dose-dependent manner. The cell viability of the 250 μg/ml ox-LDL treatment group was close to the half of the control group which was selected for the subsequent experiments (Fig. 2).
RSO protect HUVECs from ox-LDL induced cell death
RSO treatment demonstrated dose dependent protective effect compared against ox-LDL induced cell death (P < 0.01, Fig. 3).
Effect of RSO on inflammatory factors in the ox-LDL treated HUVECs
Compared with the control group, the concentrations of inflammatory factors IL-1β、IL-6、TNF-α elevated significantly in the HUVECs treated with ox-LDL, while IL-10 decreased (P < 0.01) (Fig. 4) and treatment with RSO dose dependently reverse the changes of these inflammatory factors (P < 0.01) (Fig. 4).
Effect of RSO on the expression of vascular adhesion factor of ox-LDL-treated HUVECs
RSO treatment reduced the relative mRNA and protein expression levels of monocyte chemoattractant protein (MCP-1) and VCAM-1 in ox-LDL-treated cells (P < 0.001) (Fig. 5).
The effect of RSO on ROS level of ox-LDL-treated HUVECs
The results showed that the ROS level in ox-LDL-induced injured cells was significantly higher than that of the control (P < 0.01) and RSO treatment reverse such increase in a dose dependent manner (50, 100, 150 μg/ml) (P < 0.01) (Fig. 6).
The effect of RSO on NO content and eNOS levels in ox-LDL-treated HUVECs
NO content, RNA and protein expression of eNOS in cells treated with ox-LDL were significantly lower than those in the control group (P < 0.01) (Fig. 7). RSO treatment could significant reverse the reduction of the protein levels induced by ox-LDL (P < 0.01) (Fig. 7a, b) but not significantly reverse at the mRNA levels (P > 0.05) (Fig. 7d).
The effect of RSO on TLR4/NF-κB pathway in HUVECs
250 μg/ml ox-LDL treated cells demonstrated a significant increase in TLR4 and NF-κB p65 protein expression levels (P < 0.01), which was reversed dose dependently by RSO (P < 0.05). Further the protein expression levels of TLR4 and the ratio of NF-κB p-p65/p65 were increased in the ox-LDL treated group (P < 0.01) which were dose-dependently reversed by RSO (P < 0.05) (Fig. 8).
Discussion
In the case of disturbed blood flow, endothelial cells and their tight junctions leak, which promotes the uptake of plasma LDL accumulated under the endothelium and which in turn evolves into ox-LDL (Ketelhuth and Hansson 2011). It can act on endothelial cells to stimulate the secretion of chemokines such as MCP-1, IL-6 and IL-1β and up regulate the expression of adhesion molecules such as VCAM-1 on the cell surface (Kattoor et al. 2019; Khosravi et al. 2019; Jun et al. 2022; Munjal and Khandia 2020; Ridker et al. 2011; Lin et al. 2014; Preiss and Sattar 2007). Subsequently, endothelial cell activation occurs from the oxidation reaction of these inflammatory mediators, leading to the expression of P-selectin (Woollard and Chin-Dusting 2007), E-selectin (Wenzel et al. 1994), attracts the aggregation and adhesion of monocytes, and thus promote the progress of AS process. In this work, the anti-inflammatory effects of RSO were assessed by studying the levels of related inflammatory factors compared with ox-LDL- HUVECs which simulates atherosclerosis as described (Gao et al. 2016). Our results indicated that cells treated with ox-LDL have a higher level of pro-inflammatory factors which can be reversed by RSO treatment.
In addition to inflammation, oxidative stress also plays an important role in the pathogenesis and progression of AS (Batty et al. 2022). The vascular wall can produce endogenous ROS (Zhang et al. 2022). However, excessive ROS can cause oxidative stress and damage blood vessels (Kattoor et al. 2017) and transform LDL into ox-LDL, stimulating the formation of foam cells and the release of matrix metalloproteinases (MMPs) which can promote the infiltration and migration of inflammatory mediators, and then destroy the normal structure of tissues (Yu et al. 2017; El Hadri et al. 2021). However, endothelial derived NO is a molecule that is catalyzed by eNOS and has various biological activities such as dilating blood vessels, reducing ROS, inhibiting platelet and leukocyte adhesion, and it can play an important role in cardiovascular protection and possess anti-AS functions (Wang et al. 2022). However, if the eNOS expression of endothelial cells is abnormal, the generation of NO may be affected, leading to ROS disorders and loss of protection of vascular endothelial cells and ultimately leading to AS lesions (Hong et al. 2019). The ROS content of HUVECs significantly increased while NO and eNOS levels significantly decreased under the treatment of ox-LDL, which both of which RSO reversed in a dose dependent manner indicating that RSO can alleviate the oxidative damage of HUVECs induced by ox-LDL through its antioxidant properties.
TLRs signaling pathways are considered bridges between the immune system and inflammatory diseases such as AS (Koushki et al. 2021). As an important member of the TLRs family, TLR4 which can be activated by inflammatory factors (Rocha et al. 2016), increase in carotid and coronary AS plaques in mice and humans (Xu et al. 2001). Meanwhile, Monaco et al. (Monaco et al. 2004) found that activated NF-κB can be detected in injured endothelial cells during the development of AS plaques. NF-κB is the ultimate effector molecule of the TLR4 signaling pathway and is also overexpressed in many inflammatory related diseases (Yao et al. 2019). Activated NF-κB can regulate the expression of pro-inflammatory factors, chemokines, adhesion molecules, growth factors, etc., playing a core role in inflammation (Tedgui and Mallat 2006; Tang et al. 2015). Our results showed that upregulated TLR4 and NF-κB were observed in HUVECs treated with ox-LDL and were dose-dependent reverse by RSO. Base on our results, it is speculated that RSO may reduce the secretion of inflammatory factors, chemokines, and adhesion molecules caused by ox-LDL in HUVECs by inhibiting the TLR4/NF-κB signaling pathway, thereby exerting a protective effect on HUVECs.
However, our study has the following limitations: Firstly, compared to the complex pathological and physiological processes of AS and the bioavailability of RSO in the human body, there may be an apparent distinction between in vitro and in vivo. Secondly, besides the TLR4/NF-κB signal pathway, the other mechanisms involved still need to be elucidated.
Conclusions
In summary, this work demonstrated that the anti-inflammatory and antioxidant effects of RSO on the AS cellular model were associated with the secretion of NO, IL-10 and attenuation of TNF-α, IL-1β, IL-6, MCP-1 and VCAM-1 induced by ox-LDL treatments which could be due in part to the the reduction of the induced expression of TLR4/NF-κB. Our studies identified RSO as a potential AS protective drug and our results may provide new insight into preventive targets for people at isk of suffering from AS.
References
Agency for Toxic Substances and Disease Registry (ATSDR) (2022) Toxicological profile for acetone. Agency for Toxic Substances and Disease Registry, US
Azócar L, Ciudad G, Heipieper HJ, Navia R (2010) Biotechnological processes for biodiesel production using alternative oils. Appl Microbiol Biotechnol 88(3):621–636. https://doi.org/10.1007/s00253-010-2804-z
Batty M, Bennett MR, Yu E (2022) The role of oxidative stress in atherosclerosis. Cells 11(23):3843. https://doi.org/10.3390/cells11233843
Chatzizisis YS, Coskun AU, Jonas M, Edelman ER, Feldman CL, Stone PH (2007) Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior. J Am Coll Cardiol 49(25):2379–2393. https://doi.org/10.1016/j.jacc.2007.02.059
Chen X, Zhang W, Sun L, Lian Y (2021) Tectorigenin protect HUVECs from H(2)O(2)-induced oxidative stress injury by regulating PI3K/Akt pathway. Tissue Cell 68:101475. https://doi.org/10.1016/j.tice.2020.101475
Deng J, Mai K, Chen L, Mi H, Zhang L (2015) Effects of replacing soybean meal with rubber seed meal on growth, antioxidant capacity, non-specific immune response, and resistance to Aeromonas hydrophila in tilapia (Oreochromis niloticus × O. aureus). Fish Shellfish Immunol 44(2):436–444. https://doi.org/10.1016/j.fsi.2015.03.018
El Hadri K, Smith R, Duplus E, El Amri C (2021) Inflammation, oxidative stress, senescence in atherosclerosis: thioredoxine-1 as an emerging therapeutic target. Int J Mol Sci 23(1):77. https://doi.org/10.3390/ijms23010077
Förstermann U, Sessa WC (2012) Nitric oxide synthases: regulation and function. Eur Heart J 33(7):829–837. https://doi.org/10.1093/eurheartj/ehr304
Fu Y, Cao J, Wei X, Ge Y, Su Z, Yu D (2023) Klotho alleviates contrast-induced acute kidney injury by suppressing oxidative stress, inflammation, and NF-KappaB/NLRP3-mediated pyroptosis. Int Immunopharmacol 118:110105. https://doi.org/10.1016/j.intimp.2023.110105
Gandhi VM, Cherian KM, Mulky MJ (1990) Nutritional and toxicological evaluation of rubber seed oil. J Americ Oil Chem Soc 67(11):883–886. https://doi.org/10.1007/BF02540511
Gao W, Liu H, Yuan J, Wu C, Huang D, Ma Y, Zhu J, Ma L, Guo J, Shi H, Zou Y, Ge J (2016) Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-α mediated NF-κB pathway. J Cell Mol Med 20(12):2318–2327. https://doi.org/10.1111/jcmm.12923
Grootaert MOJ, Bennett MR (2021) Vascular smooth muscle cells in atherosclerosis: time for a re-assessment. Cardiovasc Res 117(11):2326–2339. https://doi.org/10.1093/cvr/cvab046
Hong FF, Liang XY, Liu W, Lv S, He SJ, Kuang HB, Yang SL (2019) Roles of eNOS in atherosclerosis treatment. Inflamm Res 68(6):429–441. https://doi.org/10.1007/s00011-019-01229-9
Jun Q, Youhong L, Yuan Z, Xi Y, Wang B, Xinyi S, Fu Y, Kedan C, Lian J, Jianqing Z (2022) Histone modification of endothelial-mesenchymal transition in cardiovascular diseases. Front Cardiovasc Med 9:1022988. https://doi.org/10.3389/fcvm.2022.1022988
Kattoor AJ, Pothineni NVK, Palagiri D, Mehta JL (2017) Oxidative Stress in Atherosclerosis. Curr Atheroscler Rep 19(11):42. https://doi.org/10.1007/s11883-017-0678-6
Kattoor AJ, Kanuri SH, Mehta JL (2019) Role of Ox-LDL and LOX-1 in Atherogenesis. Curr Med Chem 26(9):1693–1700. https://doi.org/10.2174/0929867325666180508100950
Kaval ME, Cakir B, Polatli E, Rençber S, Karavana SY, Nalbantsoy A, Güneri P (2022) IL-1ß, IL-6 and TNF-α expression levels of macrophage cells induced by benzydamine hydrochloride, benzydamine hydrochloride with chitosan, calcium hydroxide and chlorhexidine medicaments: an ELISA study. Dent Mater J 41(4):545–551. https://doi.org/10.4012/dmj.2021-265
Ketelhuth DF, Hansson GK (2011) Cellular immunity, low-density lipoprotein and atherosclerosis: break of tolerance in the artery wall. Thromb Haemost 106(5):779–786. https://doi.org/10.1160/th11-05-0321
Khosravi M, Poursaleh A, Ghasempour G, Farhad S, Najafi M (2019) The effects of oxidative stress on the development of atherosclerosis. Biol Chem 400(6):711–732. https://doi.org/10.1515/hsz-2018-0397
Koushki K, Shahbaz SK, Mashayekhi K, Sadeghi M, Zayeri ZD, Taba MY, Banach M, Al-Rasadi K, Johnston TP, Sahebkar A (2021) Anti-inflammatory Action of Statins in Cardiovascular Disease: the role of inflammasome and toll-Like receptor pathways. Clin Rev Allergy Immunol 60(2):175–199. https://doi.org/10.1007/s12016-020-08791-9
Lin J, Kakkar V, Lu X (2014) Impact of MCP-1 in atherosclerosis. Curr Pharm Des 20(28):4580–4588. https://doi.org/10.2174/1381612820666140522115801
Liu J, Zhao L, Cai H, Zhao Z, Wu Y, Wen Z, Yang P (2022) Antioxidant and anti-inflammatory properties of rubber seed oil in lipopolysaccharide-induced RAW 267.4 macrophages. Nutrients 14(7):1349. https://doi.org/10.3390/nu14071349
Lourith N, Kanlayavattanakul M, Sucontphunt A, Ondee T (2014) Para rubber seed oil: new promising unconventional oil for cosmetics. J Oleo Sci 63(7):709–716. https://doi.org/10.5650/jos.ess14015
Miano JM, Fisher EA, Majesky MW (2021) Fate and State of Vascular Smooth Muscle Cells in Atherosclerosis. Circulation 143(21):2110–2116. https://doi.org/10.1161/circulationaha.120.049922
Monaco C, Andreakos E, Kiriakidis S, Mauri C, Bicknell C, Foxwell B, Cheshire N, Paleolog E, Feldmann M (2004) Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci U S A 101(15):5634–5639. https://doi.org/10.1073/pnas.0401060101
Munjal A, Khandia R (2020) Atherosclerosis: orchestrating cells and biomolecules involved in its activation and inhibition. Adv Protein Chem Struct Biol 120:85–122. https://doi.org/10.1016/bs.apcsb.2019.11.002
Pi Y, Ma L, Wang H, Wang J, Xu J, Bu D (2019) Rubber seed oil and flaxseed oil supplementation on serum fatty acid profile, oxidation stability of serum and milk, and immune function of dairy cows. Asian-Australas J Anim Sci 32(9):1363–1372. https://doi.org/10.5713/ajas.18.0573
Poznyak AV, Bharadwaj D, Prasad G, Grechko AV, Sazonova MA, Orekhov AN (2021) Anti-inflammatory therapy for atherosclerosis: focusing on cytokines. Int J Mol Sci 22(13):7061. https://doi.org/10.3390/ijms22137061
Preiss DJ, Sattar N (2007) Vascular cell adhesion molecule-1: a viable therapeutic target for atherosclerosis? Int J Clin Pract 61(4):697–701. https://doi.org/10.1111/j.1742-1241.2007.01330.x
Ridker PM, Thuren T, Zalewski A, Libby P (2011) Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS). Am Heart J 162(4):597–605. https://doi.org/10.1016/j.ahj.2011.06.012
Rocha DM, Caldas AP, Oliveira LL, Bressan J, Hermsdorff HH (2016) Saturated fatty acids trigger TLR4-mediated inflammatory response. Atherosclerosis 244:211–215. https://doi.org/10.1016/j.atherosclerosis.2015.11.015
Tang YL, Jiang JH, Wang S, Liu Z, Tang XQ, Peng J, Yang YZ, Gu HF (2015) TLR4/NF-κB signaling contributes to chronic unpredictable mild stress-induced atherosclerosis in ApoE-/- mice. PLoS ONE 10(4):e0123685. https://doi.org/10.1371/journal.pone.0123685
Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86(2):515–581. https://doi.org/10.1152/physrev.00024.2005
Wang L, Cheng CK, Yi M, Lui KO, Huang Y (2022) Targeting endothelial dysfunction and inflammation. J Mol Cell Cardiol 168:58–67. https://doi.org/10.1016/j.yjmcc.2022.04.011
Wenzel K, Felix S, Kleber FX, Brachold R, Menke T, Schattke S, Schulte KL, Gläser C, Rohde K, Baumann G et al (1994) E-selectin polymorphism and atherosclerosis: an association study. Hum Mol Genet 3(11):1935–1937. https://doi.org/10.1093/hmg/3.11.1935
Woollard KJ, Chin-Dusting J (2007) Therapeutic targeting of p-selectin in atherosclerosis. Inflamm Allergy Drug Targets 6(1):69–74. https://doi.org/10.2174/187152807780077345
Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC, Luthringer D, Xu XP, Rajavashisth TB, Yano J, Kaul S, Arditi M (2001) Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 104(25):3103–3108. https://doi.org/10.1161/hc5001.100631
Yao D, Dong M, Dai C, Wu S (2019) Inflammation and Inflammatory Cytokine Contribute to the Initiation and Development of Ulcerative Colitis and Its Associated Cancer. Inflamm Bowel Dis 25(10):1595–1602. https://doi.org/10.1093/ibd/izz149
Yu M, Tsai SF, Kuo YM (2017) The therapeutic potential of anti-inflammatory exerkines in the treatment of atherosclerosis. Int J Mol Sci 18(6):1260. https://doi.org/10.3390/ijms18061260
Zhang L, Huang J, Zhang D, Lei X, Ma Y, Cao Y, Chang J (2022) Targeting Reactive Oxygen Species in Atherosclerosis via Chinese Herbal Medicines. Oxid Med Cell Longev 2022:1852330. https://doi.org/10.1155/2022/1852330
Zhu Y, Xian X, Wang Z, Bi Y, Chen Q, Han X, Tang D, Chen R (2018) Research progress on the relationship between atherosclerosis and inflammation. Biomolecules 8(3):80. https://doi.org/10.3390/biom8030080
Acknowledgements
The authors thank Jiaxin Liu for assistance with the experiments and Yanchen Su for valuable discussion.
Funding
This study was funded by the Ministry of Science and Technology of Yunnan province (2020YFF0403591).
Author information
Authors and Affiliations
Contributions
Yujie Zhang, Fuchuan Huang and Tao Ding designed the study. Fuchuan Huang, Yiran Wu and Linmei Jiao performed the experiments. Yujie Zhang analyzed the data and draft the manuscript. Tao Ding and Yun Wang revised the manuscript. All authors have read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Conflict of interest
The authors declare no competing financial interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Zhang, Y., Huang, F., Wu, Y. et al. Protective effect of rubber seed oil on human endothelial cells. J Mol Histol (2024). https://doi.org/10.1007/s10735-024-10198-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10735-024-10198-1